We amplify the critical evidence for health products and services in value focused environments
Healthagen Outcomes offers analytical and advisory services that meet the market and clinical challenges faced by pharmaceutical, biotech, and device companies. Our services use real world data, advanced technologies, and professional know-how to illuminate therapeutic and economic value. We offer collaborative resources across Aetna to enable forward looking research into real-world outcomes and the realities of therapeutic use in genuine clinical settings.
Through us, customers gain unique insights from Aetna data and access to Aetna-affiliated institutions and resources. We leverage longitudinal health claims data from up to 23M Aetna members. The Healthagen team utilizes 800+ value-based contracts and 77 strategic partnerships with ACOs across the country—including their deep provider and patient relationships*. Our integration within Aetna opens access to professionals who tackle analytics, informatics, population health, consumer and provider engagement, and data exchange/aggregation. In short, we tap into an unmatched level of resources to uncover the evidence-based understanding critical to any therapeutic area.
*Feb 2016 ACS estimates
Health Economics Research
We conduct economic and clinical evidence-based research to determine the impact of therapies and technologies in real-world healthcare settings, past, present or future. We leverage medical claim, pharmacy, and laboratory data, as well as care management interactions and patient self-assessments.
Clinical Development Services
We provide services that validate new therapies, technologies, and care models in real world environments. Our level of strategic integration within the Aetna enterprise enables recruitment and engagement with qualified trial/study participants and investigators.
Value-Based Risk Assessments
As the healthcare industry moves toward value-based care, we lead evidence-based research studies to provide the data and insights that inform decision-makers on risk identification, analysis, mitigation, and benchmarking.
Our client engagements follow a systematic process to ensure maximum value and relevance. A typical arrangement proceeds in four critical steps:
- Define and assess impacted patient population
- Size clinical and financial opportunities
- Establish key opportunity drivers, risk factors and metrics
- Set program fundamentals
- Target opportunities as previously established
- Leverage Aetna, client, and third party assets as needed
- Conduct program in “real world” setting as first pass
- Employ Aetna environments and provider partners
- Monitor outcomes
- Prove impact
- Establish partnered, value-based business model
- Refine program operations
- Replicate pilot success across multiple relationships
Total Medical Members
Self Insured Employer
Fully Insured Commercial
Meet the Team
Van has a 19-year career in the healthcare, technology, and management consulting. Prior to Healthagen, Van led finance and business development for AuraSense, a biotechnology company founded by world-renowned nanomedicine authority, Dr. Chad Mirkin, and funded by AbbVie Biotech Ventures and Bill Gates, among others. The company has developed a broad array of nanoparticle-based genetic therapies and diagnostic platforms, with applications in cancer and autoimmune conditions. Prior to AuraSense, Mr. Crocker was with Booz & Company, focusing on payer/provider clients.